ATE145908T1 - 5-triazolo(3,4-i)purinderivate - Google Patents

5-triazolo(3,4-i)purinderivate

Info

Publication number
ATE145908T1
ATE145908T1 AT90117662T AT90117662T ATE145908T1 AT E145908 T1 ATE145908 T1 AT E145908T1 AT 90117662 T AT90117662 T AT 90117662T AT 90117662 T AT90117662 T AT 90117662T AT E145908 T1 ATE145908 T1 AT E145908T1
Authority
AT
Austria
Prior art keywords
substituted
triazolo
chem
alkyl
unsubstituted aryl
Prior art date
Application number
AT90117662T
Other languages
English (en)
Inventor
Fumio Suzuki
Junichi Shimada
Kenji Ohmori
Haruhiko Manabe
Kazuhiro Kubo
Akira Karasawa
Tetsuji Ohno
Shizuo Shiozaki
Akio Ishii
Katsuichi Shuto
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Application granted granted Critical
Publication of ATE145908T1 publication Critical patent/ATE145908T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT90117662T 1989-09-14 1990-09-13 5-triazolo(3,4-i)purinderivate ATE145908T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23911789 1989-09-14
JP26176189 1989-10-06

Publications (1)

Publication Number Publication Date
ATE145908T1 true ATE145908T1 (de) 1996-12-15

Family

ID=26534087

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90117662T ATE145908T1 (de) 1989-09-14 1990-09-13 5-triazolo(3,4-i)purinderivate

Country Status (8)

Country Link
EP (1) EP0417790B1 (de)
JP (1) JP2980658B2 (de)
AT (1) ATE145908T1 (de)
CA (1) CA2025413C (de)
DE (1) DE69029303T2 (de)
DK (1) DK0417790T3 (de)
ES (1) ES2097124T3 (de)
GR (1) GR3022027T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338743A (en) * 1988-06-06 1994-08-16 Fujisawa Pharmaceutical Co., Ltd. New use of the adenosine antagonist
ATE195739T1 (de) * 1989-10-20 2000-09-15 Kyowa Hakko Kogyo Kk Kondensierte purinderivate
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US6066641A (en) 1994-12-13 2000-05-23 Euro-Celtique S.A. Aryl thioxanthines
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
ES2166270B1 (es) * 1999-07-27 2003-04-01 Almirall Prodesfarma Sa Derivados de 8-fenil-6,9-dihidro-(1,2,4,)triazolo(3,4-i)purin-5-ona.
JP5274455B2 (ja) * 2006-06-23 2013-08-28 インサイト コーポレイション Ｈｍ７４ａアゴニストとしてのプリノン誘導体
KR20090025261A (ko) * 2006-06-23 2009-03-10 인사이트 코포레이션 Ｈｍ７４ａ 아고니스트로서의 퓨리논 유도체
ES2928238T3 (es) 2018-01-04 2022-11-16 Impetis Biosciences Ltd Compuestos tricíclicos, composiciones y aplicaciones medicinales de los mismos
EP3845535B1 (de) * 2018-08-30 2024-06-26 Tera Stone Co., Ltd Hydrazinopurinverbindung und triazolopurinverbindung zur hemmung von xanthinoxidase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404380A (en) * 1977-02-14 1983-09-13 Mead Johnson & Company Triazolopyrimidines

Also Published As

Publication number Publication date
ES2097124T3 (es) 1997-04-01
CA2025413C (en) 1997-11-04
EP0417790A2 (de) 1991-03-20
JPH03204879A (ja) 1991-09-06
DE69029303D1 (de) 1997-01-16
EP0417790A3 (en) 1992-03-18
DE69029303T2 (de) 1997-05-28
DK0417790T3 (da) 1997-04-07
GR3022027T3 (en) 1997-03-31
CA2025413A1 (en) 1991-03-15
EP0417790B1 (de) 1996-12-04
JP2980658B2 (ja) 1999-11-22

Similar Documents

Publication Publication Date Title
DE69321525D1 (de) Morphinan-derivate und medizinische verwendung
GR3020848T3 (en) 1,8-Naphthyridin-2-one derivatives
DE69033614D1 (de) Kondensierte Purinderivate
DK0976748T3 (da) Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet
NO177638C (no) Analogifremgangsmåte for fremstilling av en terapeutisk aktiv spiroforbindelse
DE69029303D1 (de) 5-Triazolo(3,4-i)purinderivate
DE69725585D1 (de) Phenylalkylcarbonsäure-derivate
NO921159L (no) Tiazolidinon- og oksazolidinonderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som vasodilatorer
AU8003594A (en) Quinolinecarboxylic acid derivative and salt thereof
DK0541322T3 (da) 1-Alkyl-2-acyl-1,2-disulfonylhydraziner med antineoplastisk aktivitet
DK424888D0 (da) Naphthothiazepinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne derivater
ATE83233T1 (de) Ethanon-oxime.
DK0562833T3 (da) Anti-ulcus pyridyloxyderivater, deres stilling og anvendelser

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee